60P launches malaria preventive medicine in Australia

Pharma |  News | 0 Comment | 22 Mar, 2019

60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria prevention medicine, Kodatef® (tafenoquine succinate). ...Read more

Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Pharma |  News | 0 Comment | 22 Mar, 2019

Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/dementia pipeline, including anti-amyloid beta (Abeta) protofibril anti...Read more

Hyphens Pharma inks MoU with A*STAR for Derma research

Pharma |  News | 0 Comment | 22 Mar, 2019

Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s res...Read more

Vertex receives approval for CF drug in Australia

Pharma |  News | 0 Comment | 20 Mar, 2019

Vertex Pharmaceuticals Incorporated has announced that the Therapeutic Goods Administration (TGA) of Australia has granted registration to SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) ...Read more

Blackstone to acquire AYUMI Pharmaceutical

Pharma |  News | 0 Comment | 18 Mar, 2019

Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation, pharmaceutical company in Japa...Read more

Pharmaceutics International gets EIR from FDA

Pharma |  News | 0 Comment | 18 Mar, 2019

Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) has announced that the U.S. Food and Drug Administration (FDA) has issued their Establi...Read more

Théa, OliX to develop RNAi therapies for AMD treatment

Pharma |  News | 0 Comment | 18 Mar, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and collaboration agreement with Théa Open Innovation, part of the La...Read more

Chugai’s Hemlibra receives approval for severe Hemophilia A

Pharma |  News | 0 Comment | 15 Mar, 2019

Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlibra® (emicizumab), a hemophilia A treatment originated by Chu...Read more

Aprecia, CMIC to bring 3DP pharmaceutical products to Japan

Pharma |  News | 0 Comment | 15 Mar, 2019

Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both companies will collaborate to develop business opportunities in Jap...Read more

Glenmark receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5%

Pharma |  News | 0 Comment | 15 Mar, 2019

Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic versi...Read more

Zydus set to market generic anti-diabetic drug

Pharma |  News | 0 Comment | 15 Mar, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies The company has received the tentative...Read more

Ajinomoto Bio-Pharma services announces its assets expansion

Pharma |  News | 0 Comment | 13 Mar, 2019

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading global company which is fully integrated contract development and manufacturing organization with sites in Belgium, Uni...Read more

CStone receives IND approval in China for HDAC6 inhibitor CS3003

Pharma |  News | 0 Comment | 13 Mar, 2019

CStone Pharmaceuticals announced that the National Medical Products Administration (NMPA) recently approved company's histone deacetylase 6 (HDAC6) selective inhibitor CS3003 for Phase I cl...Read more

FDA approves Regeneron, Sanofi's Dupixent to treat atopic dermatitis

Pharma |  News | 0 Comment | 12 Mar, 2019

Regeneron Pharmaceuticals and Sanofi have announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for adolescent patients 12 to...Read more

Oncoceutics licenses rights for its anti-cancer compound to Ohara

Pharma |  News | 0 Comment | 12 Mar, 2019

US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for Japan to Ohara Pharmaceutical Co., Ltd. In addition, Ohara will recei...Read more

ASLAN signs news commercialisation agreement with BioGenetics

Pharma |  News | 0 Comment | 11 Mar, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, and BioGenetics Co Ltd, a leading South Korean healthcar...Read more

TaiwanJ Pharma signs $26M deal with Newsoara Biopharma

Pharma |  News | 0 Comment | 11 Mar, 2019

TaiwanJ Pharmaceuticals has signed a $26 million contract with Newsoara Biopharma to license out its drug candidate JKB-122 for further development in Asia. On March 2nd, 2019, TaiwanJ ann...Read more

West opens new digital technology centre in India

Pharma |  News | 0 Comment | 08 Mar, 2019

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has officially opened the Company’s new Digital Technology centre (DTC)...Read more